Page last updated: 2024-09-04

moxifloxacin and Prostatitis

moxifloxacin has been researched along with Prostatitis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charlier, C; Lécuyer, H; Lortholary, O; Pilmis, B	1
Magri, V; Marras, E; Perletti, G; Restelli, A	1
Kees, F; Lunz, JC; Naber, KG; Wagenlehner, FM; Wieland, W	1
Bschleipfer, T; Wagenlehner, FM; Weidner, W	1
Groeneveld, JH; Kuijper, EJ; van Nieuwkoop, C; Visser, LG	1

Trials

2 trial(s) available for moxifloxacin and Prostatitis

Article	Year
Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Biological Availability; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prostate; Prostatic Hyperplasia; Prostatitis; Quinolines; Transurethral Resection of Prostate	2006
[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin]. Der Urologe. Ausg. A, 2007, Volume: 46, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Biomarkers, Tumor; Biopsy; Double-Blind Method; Fluoroquinolones; Humans; Male; Moxifloxacin; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatitis; Quinolines	2007

Article

Year

Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.

Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5

Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Biological Availability; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prostate; Prostatic Hyperplasia; Prostatitis; Quinolines; Transurethral Resection of Prostate

2006

[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].

Der Urologe. Ausg. A, 2007, Volume: 46, Issue:9

Topics: Anti-Infective Agents; Aza Compounds; Biomarkers, Tumor; Biopsy; Double-Blind Method; Fluoroquinolones; Humans; Male; Moxifloxacin; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatitis; Quinolines

2007

Other Studies

3 other study(ies) available for moxifloxacin and Prostatitis

Article	Year
Enterococcus faecalis-related prostatitis successfully treated with moxifloxacin. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Anti-Bacterial Agents; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis	2015
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. Anaerobe, 2010, Volume: 16, Issue:3 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Moxifloxacin; Peptostreptococcus; Prostatitis; Quinolines; Treatment Outcome	2010
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin. The Journal of infection, 2008, Volume: 56, Issue:2 Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Chronic Disease; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis; Quinolines; Recurrence; Treatment Outcome	2008